Bvf Inc Ac Immune Sa Call Options Transaction History
Bvf Inc
- $2.28 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACIU
# of Institutions
42Shares Held
26.7MCall Options Held
4.8KPut Options Held
22.2K-
Black Rock Inc. New York, NY2.61MShares$6.34 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA998KShares$2.42 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny803KShares$1.95 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL377KShares$916,3180.0% of portfolio
-
Acadian Asset Management LLC Boston, MA371KShares$901,9600.0% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $203M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...